Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2022 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, A Alonso… - Circulation, 2022 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Diabetic kidney disease: a report from an ADA Consensus Conference

KR Tuttle, GL Bakris, RW Bilous, JL Chiang… - Diabetes …, 2014 - Am Diabetes Assoc
The incidence and prevalence of diabetes mellitus have grown significantly throughout the
world, due primarily to the increase in type 2 diabetes. This overall increase in the number of …

[HTML][HTML] Heart disease and stroke statistics-2021 update: a report from the American Heart Association.

SS Virani, A Alonso, HJ Aparicio, EJ Benjamin… - 2021 - dukespace.lib.duke.edu
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

[HTML][HTML] Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes

PR Schauer, DL Bhatt, JP Kirwan… - … England Journal of …, 2017 - Mass Medical Soc
Background Long-term results from randomized, controlled trials that compare medical
therapy with surgical therapy in patients with type 2 diabetes are limited. Methods We …

[HTML][HTML] Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes

PR Schauer, DL Bhatt, JP Kirwan… - … England Journal of …, 2014 - Mass Medical Soc
Background In short-term randomized trials (duration, 1 to 2 years), bariatric surgery has
been associated with improvement in type 2 diabetes mellitus. Methods We assessed …

[HTML][HTML] KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease

IH de Boer, ML Caramori, JCN Chan… - Kidney …, 2020 - kidney-international.org
This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

GFM Strippoli, SD Navaneethan, DW Johnson… - Bmj, 2008 - bmj.com
Objective To analyse the benefits and harms of statins in patients with chronic kidney
disease (pre-dialysis, dialysis, and transplant populations). Design Meta-analysis. Data …

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

G Thomas, AR Sehgal, SR Kashyap… - Clinical journal of the …, 2011 - journals.lww.com
Results Eleven studies (n= 30,146) were included. MetS was significantly associated with
the development of eGFR< 60 ml/min per 1.73 m 2 (odds ratio, 1.55; 95% CI, 1.34, 1.80) …

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan, JC Craig… - Annals of internal …, 2010 - acpjournals.org
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …